Suction-Assisted Microneedle Delivery for Low-Trauma Cell Transfection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering nucleic acid vaccines, such as DNA vaccines, face challenges in transfection efficiency and skin trauma due to the use of costly and difficult-to-manufacture electroporation devices, which require high-intensity electric fields and cause irritation and scarring.
Innovation Solution
The use of suction to enhance permeabilization and transfection of cells by applying controlled negative pressure to the skin surface after delivering nucleic acids through microneedles, promoting the uptake and expression of nucleic acid molecules.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If electroporation is used to deliver nucleic acid vaccines, then transfection efficiency is improved, but skin trauma and manufacturing complexity increase
Solution Approach 1:
The patent replaces the electrical field-based electroporation system with a mechanical suction system. A suction device applies negative pressure to the skin surface to facilitate nucleic acid uptake by cells, eliminating the need for high-intensity electric fields while achieving comparable transfection efficiency. This substitution resolves the contradiction by maintaining reliability through mechanical means while avoiding the harmful effects of electrical trauma.
Solution Approach 2:
The invention employs pneumatic principles by using a suction device that creates negative pressure (vacuum) to draw nucleic acids into the skin and facilitate cellular uptake. The suction mechanism uses controlled negative pressure applied through a seal on the skin surface, providing an alternative to electrical methods that reduces skin trauma while maintaining transfection efficiency.
2Reliability
If electroporation devices are used for nucleic acid delivery, then transfection is achieved, but device cost and manufacturing difficulty increase
Solution Approach 1:
The patent replaces complex electrical field generation and control systems with a simple mechanical suction device. The suction device consists of basic pneumatic components that can be manufactured more easily and at lower cost compared to electroporation equipment, while achieving similar transfection results through mechanical pressure differentials rather than complex electrical circuits.
Solution Approach 2:
The invention employs disposable microneedle arrays that can be pre-coated with nucleic acids and discarded after single use. This eliminates the need for expensive, complex electroporation devices and reduces manufacturing complexity by using simple, disposable components rather than expensive, reusable electrical equipment requiring sophisticated manufacturing and maintenance.
3Productivity
If high-intensity electric fields are applied for transdermal delivery, then permeabilization of stratum corneum is achieved, but skin irritation and scarring occur
Solution Approach 1:
The patent substitutes electrical field application with mechanical suction to achieve stratum corneum permeabilization. The suction device creates negative pressure that physically draws nucleic acids through the skin barrier and into cells without the need for high-intensity electric fields, thereby maintaining delivery efficiency while eliminating skin irritation and scarring associated with electrical methods.
Solution Approach 2:
The invention introduces a suction seal as an intermediary between the delivery system and the skin. This intermediary device distributes the mechanical force evenly across the skin surface and creates a controlled microenvironment that facilitates permeabilization without the harsh effects of direct electrical field application, reducing skin irritation while maintaining delivery efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Achieves efficient transfection and expression of nucleic acids comparable to electroporation with minimal trauma and cost, allowing for rapid mass production and long shelf life of dry-coated vaccines.
Implementation Method 1
suction is used to enhance the uptake and subsequent transfection and expression of plasmid DNAs
Implementation Method 2
The suction is controlled to create a predetermine negative pressure for a predetermined period of time
Implementation Method 3
A microneedle, or array of microneedles, may be inserted through a surface of the skin to deliver the molecule transcutaneously
Data Source
AI summary
A method and apparatus for promoting the delivery of a molecule across a cell membrane comprises delivering a molecule to a delivery site of a region of tissue surrounding the cell membrane. A suction component applies a suction through a suction tip that surrounds the surface of the delivery site creating a seal to promote delivery of the molecule across the cell membrane. The application of the suction is controlled to create a predetermined negative pressure for a predetermined period of time before releasing the negative pressure. Suction is used to enhance permeabilization and transfection of cells. The technique can be used to enhance the uptake and subsequent transfection and expression of plasmid DNA vaccines, mRNA vaccines and other nucleic acid molecules, that are introduced subcutaneously. It can be used in combination with coated microneedles.